American Society of Clinical Oncology

SHERPA: White

People

  1. De Angelis
    De Angelis
  2. Gavrilovic
    Gavrilovic
  3. Kaley
    Kaley
  4. Nolan
    Nolan
  5. Mellinghoff
    Mellinghoff
  6. Pentsova
    Pentsova
  7. Panageas
    Panageas
  8. Correa
    Correa
  9. Grommes
    Grommes
  10. Gutin
    Gutin

Groups

  1. Tow Center for Developmental Oncology (TCDO) (10)
  2. GSK Faculty (5)
  3. Human Oncology and Pathogenesis Program (5)
  4. Biostatistics Service (3)
  5. Epidemiology and Biostatistics (3)
  6. Neuroradiology Service (3)
  7. Population Sciences Research Program (3)
  8. Radiology, Department of (3)
  9. Survivorship Research (3)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (2)
Search Within
  1. "Lisa De Angelis"
  2. "Igor Gavrilovic"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (3)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (10)
  2. GSK Faculty (5)
  3. Human Oncology and Pathogenesis Program (5)
  4. Biostatistics Service (3)
  5. Epidemiology and Biostatistics (3)
  6. Neuroradiology Service (3)

More Groups

People
  1. Igor Gavrilovic (10)
  2. Lisa De Angelis (10)
  3. Craig Nolan (6)
  4. Lauren Abrey (6)
  5. Thomas Kaley (6)
  6. Adilia Hormigo (5)

More People

Years
  1. 2018 (2)
  2. 2016 (1)
  3. 2013 (1)
  4. 2012 (1)
  5. 2011 (1)
  6. 2010 (1)

More Years

Publications
  1. Journal of Clinical Oncology (10)

Results (10)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patients' education about a new service available at Memorial Sloan Kettering Multidisciplinary Clinic for frail patients with central nervous system cancers
    Meeting Abstract

    Pentsova, E.; Purisic, I.; Zavolas, S.; Skakodub, A.; Nevel, K. S.; Kaley, T. J.; Lin, A.; Daras, M.; Gavrilovic, I. T.; DeAngelis, L. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Multicenter phase IB trial of carboxyamidotriazole orotate and temozolomide for recurrent and newly diagnosed glioblastoma and other anaplastic gliomas
    Journal Article

    Omuro, A.; Beal, K.; McNeill, K.; Young, R. J.; Thomas, A.; Lin, X.; Terziev, R.; Kaley, T. J.; DeAngelis, L. M.; Daras, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Multicenter phase IB trial of carboxyamidotriazole orotate (CTO) combined with temozolomide (TMZ) for recurrent glioblastoma (GBM) and other malignant gliomas (MG)
    Meeting Abstract

    Lin, X.; Kaley, T. J.; Pentsova, E.; DeAngelis, L. M.; Daras, M.; Gavrilovic, I. T.; Mellinghoff, I. K.; McKeown, A.; Manne, M.; Hansen, J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase I trial of temsirolimus (TEM) and perifosine (PER) for recurrent or progressive malignant glioma (MG)
    Meeting Abstract

    Kaley, T. J.; Pentsova, E.; Omuro, A. M. P.; Mellinghoff, I. K.; Nolan, C.; Gavrilovic, I. T.; DeAngelis, L. M.; Lacouture, M. E.; Holland, E. C.; Lassman, A. B.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Rituximab, methotrexate (MTX), procarbazine, and vincristine (R-MPV) followed by consolidation high-dose chemotherapy (HDC) and autologous stem-cell transplant (ASCT) for newly diagnosed primary CNS lymphoma (PCNSL)
    Meeting Abstract

    Omuro, A. M. P.; Correa, D.; Moskowitz, C.; Matasar, M. J.; DeAngelis, L. M.; Kaley, T. J.; Gavrilovic, I. T.; Nolan, C.; Pentsova, E.; Grommes, C.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase II study of bevacizumab (BEV), temozolomide (TMZ), and hypofractionated stereotactic radiotherapy (HFSRT) for newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M. P.; Beal, K.; Karimi, S.; Correa, D.; Chan, T. A.; DeAngelis, L. M.; Gavrilovic, I. T.; Nolan, C.; Hormigo, A.; Lassman, A. B.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II trial of continuous low-dose temozolomide (TMZ) for recurrent malignant glioma (MG) with and without prior exposure to bevacizumab (BEV)
    Meeting Abstract

    Khasraw, M.; Abrey, L. E.; Lassman, A. B.; Hormigo, A.; Nolan, C.; Gavrilovic, I. T.; Mellinghoff, I. K.; Reiner, A. S.; DeAngelis, L. M.; Omuro, A. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma
    Journal Article

    Clarke, J. L.; Iwamoto, F. M.; Sul, J.; Panageas, K.; Lassman, A. B.; DeAngelis, L.; Hormigo, A.; Nolan, C. P.; Gavrilovic, I.; Karimi, S.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A randomized phase II trial of concurrent temozolomide (TMZ) and radiotherapy (RT) followed by dose dense compared to metronomic TMZ and maintenance cis-retinoic acid for patients with newly diagnosed glioblastoma multiforme (GBM)
    Meeting Abstract

    Sul, J.; Panageas, K. S.; Lassman, A. B.; Hormigo, A.; Nolan, C.; Gavrilovic, I. T.; Grimm, S. A.; DeAngelis, L. M.; Abrey, L. E.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma
    Journal Article

    Gavrilovic, I. T.; Hormigo, A.; Yahalom, J.; Deangelis, L. M.; Abrey, L. E.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save